Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Oceania Healthcare ( (NZ:OCA) ) has shared an announcement.
Oceania Healthcare reported a record full-year result for FY26, with sales volumes up 16%, Proforma Underlying EBITDA rising 20% to $97.7m, and net debt cut by $121.4m to $506.7m, bringing gearing to the bottom of its target range. The group increased total assets to $3.1bn, boosted care profitability through premiumisation, and delivered $13.2m of cost savings, even as statutory net profit fell sharply due to lower property revaluations and the prior closure of its nursing education institute.
The company achieved strong sales and development momentum despite a subdued housing market, lifting the gross value of settled sales to $375m, reducing unsold stock by a net 34%, and nearing full development recovery at its flagship Helier village in Auckland. Oceania continued to reshape its portfolio via the divestment of seven sites and a tighter build programme, prioritising cash generation and debt reduction, and while free cash outflows improved materially, the board has suspended dividends for FY26 until operations generate positive free cash flow.
More about Oceania Healthcare
Oceania Healthcare is a New Zealand-based aged care and retirement village operator listed on the NZX and ASX. The company focuses on integrated villages combining aged care beds and independent retirement units, with an emphasis on premium care suites and higher-end retirement living, particularly in key urban markets such as Auckland.
Average Trading Volume: 573,329
Technical Sentiment Signal: Strong Sell
Current Market Cap: N$463.5M
For an in-depth examination of OCA stock, go to TipRanks’ Overview page.